Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.585
+0.025 (1.60%)
Mar 14, 2025, 10:55 AM EDT - Market open

Aclaris Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Aclaris Therapeutics stock have an average target of 11.67, with a low estimate of 7.00 and a high estimate of 20. The average target predicts an increase of 636.28% from the current stock price of 1.59.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $11.67 $13 $20
Change +341.64% +636.28% +720.19% +1161.8%

Analyst Ratings

The average analyst rating for Aclaris Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 023333
Buy 122223
Hold 520000
Sell 000000
Strong Sell 000000
Total 665556

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Scotiabank
Scotiabank
Buy
Initiates
$15
Buy Initiates $15 +846.37% Mar 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$20
Strong Buy Upgrades $20 +1,161.83% Dec 23, 2024
Leerink Partners
Leerink Partners
Buy
Upgrades
$2$7
Buy Upgrades $2$7 +341.64% Nov 19, 2024
Jefferies
Jefferies
Strong Buy
Upgrades
$2$7
Strong Buy Upgrades $2$7 +341.64% Nov 19, 2024
BTIG
BTIG
Strong Buy
Upgrades
$8
Strong Buy Upgrades $8 +404.73% Nov 19, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
9.16M
from 18.72M
Decreased by -51.07%
Revenue Next Year
8.42M
from 9.16M
Decreased by -8.05%
EPS This Year
-0.56
from -1.71
EPS Next Year
-0.70
from -0.56
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
6.48M6.76M29.75M31.25M18.72M9.16M8.42M11.37M
Revenue Growth
53.35%4.30%340.05%5.03%-40.09%-51.07%-8.05%34.99%
EPS
-1.20-1.60-1.33-1.27-1.71-0.56-0.70-0.82
EPS Growth
--------
Forward PE
--------
No. Analysts -----974
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 20.9M 22.9M 25.1M
Avg 9.2M 8.4M 11.4M
Low 2.5M 2.5M 2.9M

Revenue Growth

Revenue Growth 20252026202720282029
High
11.6%
149.9%
197.9%
Avg
-51.1%
-8.0%
35.0%
Low
-86.4%
-72.2%
-65.2%

EPS Forecast

EPS 20252026202720282029
High -0.16 -0.51 -0.78
Avg -0.56 -0.70 -0.82
Low -0.96 -0.91 -0.85

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.